The conference has been accredited 14 CME Hours
Therapeutics Discovery, Phase 1 and early phase clinical trial activities are the target of Kingdom of Saudi Arabia to enter the world of making and marketing new medicines.
In the last decade 56% of novel therapies are originated from the Academia and Biotech companies and 71% were “me-too” drugs coming from the Pharmaceutical companies.
The conference is intended for Pre-clinical and clinical researchers in:Academia, the Pharmaceutical and Biotechnology Industry, contract research organizations, API manufacturers domestic and international regulatory agencies in positions to affect the science and regulation of drug discovery and development, Scientists and researchers who wish to stay abreast on the national and international initiatives affecting the development of safe and effective pharmaceutical drug products.
Registration fee : 200 SAR - Online registration will close on 10 October , 2017 at 11:00 am
EXECUTIVE DIRECTOR MESSAGE
On behalf of King Abdullah International Medical Research Center (KAIMRC), it is an honor to welcome you to the “Therapeutics Discovery from Bench to First In-Human Trials” symposium held at the King Saud bin Abdulaziz University for Health Sciences Convention Center in Riyadh, Saudi Arabia. In alignment with the Saudi Arabia Vision 2030, KAIMRC is leading a transformation in biomedical research at the Kingdom of Saudi Arabia to transfer basic research into tangible products that impact health and economy. The “Therapeutics Discovery From Bench to First in Human Trials” symposium provides a unique opportunity for experts around the world to come together, learn and discuss the latest research update on drug discovery and development. The symposium will focus on important aspects related to the process of planning a Phase I clinical trial as well as the Kingdom’s readiness to conduct Phase I clinical trials. The research discoveries of the Ministry of National Guard – Health Affairs and King Abdullah International Medical Research Center will be showcased with the intension of creating a platform and opportunity for exchange and collaboration between local and international researchers on therapeutics discovery and Phase 1 clinical trials.
We invite participants to network, exchange thoughts and build collaborations during this 2-day symposium. We wish you all a great success and a pleasant stay in Riyadh.
Executive Director, KAIMRC
The King Abdullah International Medical Research Centre (KAIMRC) welcome you to this first of its kind conference in Kingdom of Saudi Arabia and region on Therapeutics Discovery and Clinical Trials.
Up on my nomination to lead the scientific team, I was thrilled by the conference theme with the aim to contribute in KSA’s 2030 vision through improving the population health and wealth.
The scientific team was very objective to propose topics that are important for all attendees planning to build the infrastructure for therapeutics discovery. Alongside, they selected very renowned scientists to present their experiences and recommendations in this very cutting edge scientific research.
We welcome you all.
Dr. Mohamed Boudjelal
Chairman of the Scientific Committee